13 June 2022
Is your viral vaccine pure and consistent?
One of the biggest challenges in developing viral vaccines is ensuring and documenting that the downstream process consistently produces a safe product – with low Host Cell Proteins (HCPs) levels.
Join Ejvind Mortz on June 29:
Learn how one LC-MS assay identifies and quantifies all proteins in the product – irrespective of the protein source.
Learn more about his webinar and sign up here >>